Zhuikov Vsevolod A, Zhuikova Yuliya V, Makhina Tatiana K, Myshkina Vera L, Rusakov Alexey, Useinov Alexey, Voinova Vera V, Bonartseva Garina A, Berlin Alexandr A, Bonartsev Anton P, Iordanskii Alexey L
Research Center of Biotechnology of the Russian Academy of Sciences 33, Bld. 2 Leninsky Ave, 119071 Moscow, Russia.
Federal State Budgetary Institution "Technological Institute for Superhard and Novel Carbon Materials", 7a Tsentralnaya Street, Troitsk, 108840 Moscow, Russia.
Polymers (Basel). 2020 Mar 24;12(3):728. doi: 10.3390/polym12030728.
The hydrolytic and enzymatic degradation of polymer films of poly(3-hydroxybutyrate) (PHB) of different molecular mass and its copolymers with 3-hydroxyvalerate (PHBV) of different 3-hydroxyvalerate (3-HV) content and molecular mass, 3-hydroxy-4-methylvalerate (PHB4MV), and polyethylene glycol (PHBV-PEG) produced by the by controlled biosynthesis technique were studied under in vitro model conditions. The changes in the physicochemical properties of the polymers during their in vitro degradation in the pancreatic lipase solution and in phosphate-buffered saline for a long time (183 days) were investigated using different analytical techniques. A mathematical model was used to analyze the kinetics of hydrolytic degradation of poly(3-hydroxyaklannoate)s by not autocatalytic and autocatalytic hydrolysis mechanisms. It was also shown that the degree of crystallinity of some polymers changes differently during degradation in vitro. The total mass of the films decreased slightly up to 8-9% (for the high-molecular weight PHBV with the 3-HV content 17.6% and 9%), in contrast to the copolymer molecular mass, the decrease of which reached 80%. The contact angle for all copolymers after the enzymatic degradation decreased by an average value of 23% compared to 17% after the hydrolytic degradation. Young's modulus increased up to 2-fold. It was shown that the effect of autocatalysis was observed during enzymatic degradation, while autocatalysis was not available during hydrolytic degradation. During hydrolytic and enzymatic degradation in vitro, it was found that PHBV, containing 5.7-5.9 mol.% 3-HV and having about 50% crystallinity degree, presents critical content, beyond which the structural and mechanical properties of the copolymer have essentially changed. The obtained results could be applicable to biomedical polymer systems and food packaging materials.
在体外模型条件下,研究了通过可控生物合成技术制备的不同分子量的聚(3-羟基丁酸酯)(PHB)及其与不同3-羟基戊酸酯(3-HV)含量和分子量的3-羟基戊酸酯(PHBV)、3-羟基-4-甲基戊酸酯(PHB4MV)和聚乙二醇(PHBV-PEG)的聚合物薄膜的水解和酶促降解。使用不同的分析技术研究了聚合物在胰脂肪酶溶液和磷酸盐缓冲盐水中长时间(183天)体外降解过程中其物理化学性质的变化。采用数学模型分析了聚(3-羟基链烷酸酯)通过非自催化和自催化水解机制的水解降解动力学。还表明,一些聚合物的结晶度在体外降解过程中变化不同。薄膜的总质量略有下降,最高可达8-9%(对于3-HV含量为17.6%和9%的高分子量PHBV),相比之下,共聚物分子量的下降达到80%。酶促降解后所有共聚物的接触角平均下降23%,而水解降解后为17%。杨氏模量增加了2倍。结果表明,在酶促降解过程中观察到自催化作用,而在水解降解过程中不存在自催化作用。在体外水解和酶促降解过程中,发现含有5.7-5.9摩尔%3-HV且结晶度约为50%的PHBV呈现临界含量,超过该含量后共聚物的结构和力学性能发生了本质变化。所得结果可应用于生物医学聚合物系统和食品包装材料。